Basic Information
Kernal Biologics has developed mRNA therapies to treat diseases such as COVID-19 and cancer. Our mRNA therapies instruct specific cells on how to produce their own medicine. Our team has successfully built a biotech company at MIT, Harvard, and major pharmaceutical companies, and possesses deep expertise in the mRNA field.
Kernal Biologics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
August 01, 2016
kernal@kernalbio.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios